Global $67B+ Womens Health Market Landscape 2024-2030: Analysis by Age, Application and Region
Dublin, Jan. 11, 2024 (GLOBE NEWSWIRE) -- The "Global Womens Health Market Size, Share & Trends Analysis Report…
25,585€
0,08%
Echtzeit-Aktienkurs Myovant Sciences Ltd.
Bid:
Ask:
Nachrichten zur Myovant Sciences Ltd. Aktie
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences, Ltd. - MYOV
NEW YORK, Nov. 05, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences, Ltd. - MYOV
NEW YORK, Oct. 27, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences, Ltd. - MYOV
NEW YORK, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences, Ltd. - MYOV
NEW YORK, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences, Ltd. - MYOV
NEW YORK, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences, Ltd. - MYOV
NEW YORK, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
Sumitovant Biopharma completes acquisition of Myovant Sciences
The deal was announced on 23 October 2022. Sumitovant has acquired all outstanding shares of Myovant it did not own…
Insiderhandel: Insider kauft Aktien von Myovant Sciences im Wert von 1.393.178.400$
Sumitomo Chemical Co., Ltd. - Zehn-Prozent-Eigentümer - Tag der Transaktion: 2023-03-10...…
Form 8-K Myovant Sciences Ltd. For: Mar 10
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Sumitovant Biopharma Completes Acquisition of Myovant Sciences
NEW YORK and BASEL, Switzerland, March 10, 2023 /PRNewswire/ -- Sumitovant Biopharma Ltd. ("Sumitovant") and Myovant Sciences Ltd. ("Myovant") announced…
XFRA : Deletion of Instruments from Boerse Frankfurt - 09.03.2023
The following instruments on Boerse Frankfurt do have their last trading day on 09.03.2023
Die folgenden Instrumente in Boerse Frankfurt haben…
Form 8-K Myovant Sciences Ltd. For: Mar 01
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Myovant Sciences (MYOV) Reports Q3 Loss, Lags Revenue Estimates
Myovant Sciences (MYOV) delivered earnings and revenue surprises of -5.36% and 3.44%, respectively, for the quarter ended December 2022. Do…
Myovant Sciences Announces Corporate Updates and Financial Results for Third Fiscal Quarter 2022
BASEL, Switzerland, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV), a biopharmaceutical company that aspires to redefine…
Form 10-Q Myovant Sciences Ltd. For: Dec 31
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K Myovant Sciences Ltd. For: Jan 26
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Insiderhandel: Chief Medical Officer verkauft Aktien von Myovant Sciences im Wert von 29.821$
Ferreira, Juan Camilo Arjona - Vorstand - Tag der Transaktion: 2023-01-18...…
Insiderhandel: Chief Commercial Officer verkauft Aktien von Myovant Sciences im Wert von 53.995$
Merendino, Lauren - Vorstand - Tag der Transaktion: 2023-01-18...…
Insiderhandel: General Counsel & Corp. Secy. verkauft Aktien von Myovant Sciences im Wert von 34.204$
Lang, Matthew - Vorstand - Tag der Transaktion: 2023-01-18...…
Insiderhandel: Principal Executive Officer verkauft Aktien von Myovant Sciences im Wert von 216.115$
Marek, David C. - Vorstand - Tag der Transaktion: 2023-01-18...…
MYOVANT SCIENCES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Myovant Sciences - MYOV
NEW ORLEANS, Jan. 11, 2023 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law…